Life Sciences Communication professor Dietram Scheufele served on the international committee examining the implications of human gene editing, and their report titled “Human Genome Editing: Science, Ethics, and Governance” was released today, February 14, 2017.
Human gene editing is not a new concept, however, with the emergence of CRISPR-Cas9, scientists are able to alter genes more efficiently and precisely than before. In 2015, the National Academies of Sciences, Engineering and Medicine convened a consensus committee to better understand the clinical, ethical, legal, and social implications of this technology.
The international committee featured experts in science, law, political science, and industry from around the globe, including Scheufele and UW-Madison law and bioethics professor R. Alto Charo who co-chaired the panel.
Many of the questions posed to the panel were inevitably linked to science communication and Scheufele, who publishes extensively on public opinion of emerging technologies, was able to provide expertise to this multidisciplinary group.
According to the NASEM, “[the report] considers important questions about the human application of genome editing including: balancing potential benefits with unintended risks, governing the use of genome editing, incorporating societal values into clinical applications and policy decisions, and respecting the inevitable differences across nations and cultures that will shape how and whether to use these new technologies.” Among the report’s contributions, it recommends criteria for germline editing, outlines the critical need for public engagement, and proposes seven general principles for the governance of human gene editing across the globe.
For more information on the report, see the following story by University Communications. Keep up with the discussion on Twitter at #GeneEditStudy. The full report is available for download via the NASEM website.
Story adapted from University Communications.